v3.26.1
Segment information - Significant Expenses by Segment (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
segment
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
segment
Segment and geographic information        
Number of operating segments | segment 1 1 1 1
Number of reportable segments | segment 1 1 1 1
Total revenues $ 360,519 $ 178,875 $ 633,070 $ 1,354,971
Net income (loss) attributable to common stockholders 83,496 (64,849) 80,687 801,713
Income tax expense (benefit) 14,049 (6,203) 14,396 57,063
Amortization 11,841 4,061 23,422 7,859
Operating segments | Life Science        
Segment and geographic information        
Total revenues 360,519 178,875 633,070 1,354,971
Cost of product, collaboration and license sales 10,933 8,093 30,611 15,800
Program spend 42,580 49,705 80,125 97,863
Employee costs 68,348 65,593 144,469 133,292
Manufacturing costs 6,232 19,519 15,317 34,470
Administrative costs 16,547 17,896 33,236 36,310
Occupancy costs 7,493 6,643 15,848 13,825
Other segment items 124,890 76,275 232,777 221,698
Net income (loss) attributable to common stockholders 83,496 (64,849) 80,687 801,713
Interest income (18,119) (20,991) (36,104) (38,236)
Interest expense 66,600 51,349 133,615 102,686
Income tax expense (benefit) 14,049 (6,203) 14,396 57,063
Depreciation 4,009 3,573 7,815 7,031
Amortization 11,841 4,061 23,422 7,859
All other 46,510 44,486 89,633 85,295
Total other segment items $ 124,890 $ 76,275 $ 232,777 $ 221,698